| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO | Director
2 companies
Torley Helen is a President And CEO at HALOZYME THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 28 sells.
Estimated insider holdings value: $54.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $58.11 | $1,743,301.60 | -1.0% | -29.8% | -31.6% | |
| Nov 17, 2022 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $53.39 | $1,601,626.38 | -1.3% | -6.7% | -24.3% | |
| Nov 8, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $39.82 | $1,990,767.78 | -4.4% | -13.1% | +16.2% | |
| Oct 4, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $40.09 | $2,004,389.86 | -4.4% | +2.7% | +3.9% | |
| Sep 7, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $42.38 | $2,118,846.08 | -4.4% | -23.6% | -8.2% | |
| Aug 10, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $41.11 | $2,055,576.04 | -1.5% | -4.4% | +6.9% | |
| Jul 6, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $45.97 | $2,298,650.00 | -8.5% | -13.4% | +1.2% | |
| Jun 7, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $39.66 | $1,982,950.00 | -8.5% | +6.7% | +14.3% | |
| May 11, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $43.02 | $2,151,098.66 | -2.2% | -5.2% | -9.6% | |
| Apr 5, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $42.55 | $2,127,250.00 | -8.5% | +7.6% | -3.4% |